Literature DB >> 421090

Rifampicin-induced non-responsiveness to corticosteroid treatment in nephrotic syndrome.

W Hendrickse, J McKiernan, M Pickup, J Lowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 421090      PMCID： PMC1597674          DOI： 10.1136/bmj.1.6159.306

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function.

Authors:  G A Buffington; J H Dominguez; W F Piering; L A Hebert; H M Kauffman; J Lemann
Journal:  JAMA       Date:  1976-10-25       Impact factor: 56.272

2.  Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.

Authors:  O C Green; R J Winter; F S Kawahara; L S Phillips; P R Lewy; R L Hart; L M Pachman
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

3.  Dose dependent pharmacokinetics of prednisolone.

Authors:  M E Pickup; J R Lowe; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953
  3 in total
  11 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Alterations of glucocorticoid actions by other drugs and disease states.

Authors:  W Jubiz; A W Meikle
Journal:  Drugs       Date:  1979-08       Impact factor: 9.546

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.

Authors:  K H Lee; J G Shin; W S Chong; S Kim; J S Lee; I J Jang; S G Shin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Controlled trial of rifampicin and ethambutol in Crohn's disease.

Authors:  J L Shaffer; S Hughes; B D Linaker; R D Baker; L A Turnberg
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

Review 6.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

Review 7.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

8.  Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.

Authors:  L Ost; I Björkhem; C von Bahr
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  Rifampicin reduces effectiveness and bioavailability of prednisolone.

Authors:  W A McAllister; P J Thompson; S M Al-Habet; H J Rogers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.